Skip to content

S. 1264 · 118th Congress (2023–2025)

SMART Prices Act

This bill modifies requirements of the Medicare Drug Price Negotiation Program and makes other changes with respect to the prices of prescription drugs under Medicare.

Current law requires the Centers for Medicare & Medicaid Services (CMS) to negotiate maximum prices for brand-name drugs that do not have other generic equivalents and that account for the greatest Medicare spending. The CMS must negotiate the prices of 10 drugs that are covered under the Medicare prescription drug benefit in 2026, 15 drugs that are covered under the Medicare prescription drug benefit in 2027, 15 drugs that are covered under the Medicare prescription drug benefit or under Medicare medical services in 2028, and 20 drugs that are covered under the Medicare prescription drug benefit or under Medicare medical services in 2029 and each year thereafter.

The bill requires the CMS to negotiate the prices of 20 drugs under the Medicare prescription drug benefit in 2026 and 40 drugs under the Medicare prescription drug benefit or under Medicare medical services in 2027 and each year thereafter. It also (1) shortens the required period of market approval from 7 years and 11 years for drugs and biologics, respectively, to 3 years; and (2) modifies the ceiling for the maximum fair price for short-, extended-, and long-monopoly drugs.

The bill also repeals provisions that prohibit the CMS from interfering in negotiations between drug manufacturers, pharmacies, and PDP sponsors (i.e., noninterference clause).

Show official title

A bill to amend title XVIII of the Social Security Act to strengthen the drug pricing reforms in the Inflation Reduction Act.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 1264’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Amy Klobuchar (D-MN)
Cosponsors
29 cosponsors

23 original · 6 later

27 D · 2 I

  1. Sen. Sherrod Brown (D-OH)· Original · Apr 25, 2023
  2. Sen. Tammy Baldwin (D-WI)· Original · Apr 25, 2023
  3. Sen. Richard Blumenthal (D-CT)· Original · Apr 25, 2023
  4. Sen. Cory A. Booker (D-NJ)· Original · Apr 25, 2023
  5. Sen. Maria Cantwell (D-WA)· Original · Apr 25, 2023
  6. Sen. Benjamin L. Cardin (D-MD)· Original · Apr 25, 2023
  7. Sen. Catherine Cortez Masto (D-NV)· Original · Apr 25, 2023
  8. Sen. Richard J. Durbin (D-IL)· Original · Apr 25, 2023
  9. Sen. Tammy Duckworth (D-IL)· Original · Apr 25, 2023
  10. Sen. Kirsten E. Gillibrand (D-NY)· Original · Apr 25, 2023
  11. Sen. Martin Heinrich (D-NM)· Original · Apr 25, 2023
  12. Sen. Margaret Wood Hassan (D-NH)· Original · Apr 25, 2023
  13. Sen. Angus S. King Jr. (I-ME)· Original · Apr 25, 2023
  14. Sen. Edward J. Markey (D-MA)· Original · Apr 25, 2023
  15. Sen. Patty Murray (D-WA)· Original · Apr 25, 2023
  16. Sen. Jeff Merkley (D-OR)· Original · Apr 25, 2023
  17. Sen. Jack Reed (D-RI)· Original · Apr 25, 2023
  18. Sen. Debbie Stabenow (D-MI)· Original · Apr 25, 2023
  19. Sen. Jeanne Shaheen (D-NH)· Original · Apr 25, 2023
  20. Sen. Tina Smith (D-MN)· Original · Apr 25, 2023
  21. Sen. Peter Welch (D-VT)· Original · Apr 25, 2023
  22. Sen. Sheldon Whitehouse (D-RI)· Original · Apr 25, 2023
  23. Sen. Elizabeth Warren (D-MA)· Original · Apr 25, 2023
  24. Sen. Raphael G. Warnock (D-GA)· Later · May 10, 2023
  25. Sen. Michael F. Bennet (D-CO)· Later · May 11, 2023
  26. Sen. John Fetterman (D-PA)· Later · May 11, 2023
  27. Sen. Bernard Sanders (I-VT)· Later · May 11, 2023
  28. Sen. Chris Van Hollen (D-MD)· Later · May 11, 2023
  29. Sen. Christopher Murphy (D-CT)· Later · Jul 26, 2023
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Finance.

    Sources
  3. Expired

    Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.

Committees

  1. SenateFinanceReferred Apr 25, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (3)
  1. SMART Prices Act

    Display title, Short title · Introduced in Senate

  2. Strengthening Medicare and Reducing Taxpayer Prices Act

    Short title · Introduced in Senate

  3. A bill to amend title XVIII of the Social Security Act to strengthen the drug pricing reforms in the Inflation Reduction Act.

    Official title · Introduced in Senate